The Jaeger Lab uses a multidisciplinary approach to identify and quantify tumor antigens that are presented by Major Histocompatibility Complexes (MHC-I and MHC-II). Utilizing tissue culture and sophisticated mouse models, our lab seeks to contribute novel methods and quality data to the growing field of immunopeptidomics. We hope to use these molecular insights to guide the next generation of precision cancer immunotherapies.